Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 21, 2022
Merck will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
read more
Monday, November 06, 2023
TC BioPharm, a clinical-stage biotechnology company focused on developing allogeneic gamma-delta T cell therapies for cancer, has chosen Fortrea as its Contract Research Organization (CRO) for conducting global trials, including ACHIEVE and ACHIEVE2,...
read more
Cirrus Pharmaceuticals, a Kemwell company, has announced that Andrew Hamer has joined as VP R&D.
read more
Wednesday, September 28, 2016
The global contract manufacturing organization (CMO) market is transforming to leverage changes in the pharmaceutical industry. Pharmaceutical companies continue to gain financially and overcome marketplace challenges, source innovative ideas, ...
read more
Smithers Viscient announced that it appointed Rohit Harve to the role of Vice President, North American Operations.
read more
Tuesday, October 17, 2017
Plasticell has entered into a collaboration with GSK to use CombiCult, to optimize the directed differentiation of iPSCs to specific blood cell lineages for use by GSK in its therapeutic research.
read more
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has formed a partnership with VectorBuilder, a vector design, optimization and manufacturing company. Univercells ...
read more
Tuesday, December 05, 2023
In November 2023, Vetter officially joined the Science Based Targets Initiative (SBTi) membership group, aligning with the global commitment to achieve climate neutrality by 2050—representing the most stringent climate protection goals for companies ...
read more
AbbVie and Capstan Therapeutics announced a definitive agreement under which AbbVie will acquire Capstan, including CPTX2309, a potential first-in-class in vivo tLNP anti-CD19 CAR-T therapy candidate, currently in Phase 1, in development for the ...
read more
Tuesday, October 09, 2018
Lonza announced an expansion of its highly potent API capacity for the specific support of antibody drug conjugate payload manufacturing.
read more
BIA Separations announced it is collaborating with AveXis to enhance the commercial purification process for its gene therapy pipeline, beginning with Zolgensma®.
read more
Wednesday, January 22, 2020
BridgeBio Pharma announced a collaboration agreement with Catalent to establish dedicated gene therapy development and manufacturing capacity at Catalent’s Paragon Gene Therapy clinical and commercial manufacturing center.
read more
ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, has advanced its hybrid central lab model in Mumbai with a state-of-the art operational facility dedicated to manage ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
DSG, Inc., a provider of eClinical technology solutions, data management, professional services and customer support recently opened a new office in Bangalore, India, to accommodate rapid growth and better serve client needs.
read more